Market closed
MEI Pharma Inc./$MEIP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MEI Pharma Inc.
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.
Ticker
$MEIP
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
28
Website
MEI Pharma Inc. Metrics
BasicAdvanced
$13M
-
-$5.74
0.61
-
Price and volume
Market cap
$13M
Beta
0.61
52-week high
$2.65
52-week low
$1.73
Average daily volume
10K
Financial strength
Current ratio
10.662
Quick ratio
10.38
Management effectiveness
Return on assets (TTM)
-30.67%
Return on equity (TTM)
-93.69%
Valuation
Price to book
0.58
Price to tangible book (TTM)
0.58
Price to free cash flow (TTM)
-0.353
Growth
Revenue change (TTM)
-100.00%
Earnings per share change (TTM)
-292.59%
3-year earnings per share growth (CAGR)
-25.36%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for MEI Pharma Inc. stock?
MEI Pharma Inc. (MEIP) has a market cap of $13M as of April 16, 2025.
What is the P/E ratio for MEI Pharma Inc. stock?
The price to earnings (P/E) ratio for MEI Pharma Inc. (MEIP) stock is 0 as of April 16, 2025.
Does MEI Pharma Inc. stock pay dividends?
No, MEI Pharma Inc. (MEIP) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next MEI Pharma Inc. dividend payment date?
MEI Pharma Inc. (MEIP) stock does not pay dividends to its shareholders.
What is the beta indicator for MEI Pharma Inc.?
MEI Pharma Inc. (MEIP) has a beta rating of 0.61. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.